ArticleThe Lancet. Microbe2021
COVID-19 drug practices risk antimicrobial resistance evolution.
Abstract read
In one paragraph
Article in The Lancet. Microbe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- SARS-CoV-2 Infection disrupts lower respiratory tract microbiome function and interactions.BMC microbiology · 2026Article
- A Novel Bioinformatics Pipeline and a Machine-Learning Approach for Antimicrobial Resistance Phenotypic Prediction.Bioinformatics and biology insights · 2026Article
- Incidence, clinical and genomic trends of hospital- and Non-hospital-onset KPC-producing Klebsiella pneumoniae infections before and during the COVID-19 era: a ten-year interrupted time series study.Antimicrobial resistance and infection control · 2025Article
- Impact of the COVID-19 Pandemic on Hospital Antimicrobial Purchasing in Canada (2018-2021): An Exploratory Analysis.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2025Article
- Mitigating Antibiotic Resistance: The Utilization of CRISPR Technology in Detection.Biosensors · 2024Review
- Microbiome Geographic Population Structure (mGPS) Detects Fine-Scale Geography.Genome biology and evolution · 2024Article
- Bacteriophage entrapment strategies for the treatment of chronic wound infections: a comprehensive review.Archives of microbiology · 2024Review
- Article
- Fluorescence sensor based on optimized quantum yield manganese-carbon polymer dots and smartphone-integrated sensing platform for tetracycline detection.Mikrochimica acta · 2024Article
- Recent Advances in the Development of Antibiotics-Coated Gold Nanoparticles to Combat Antimicrobial Resistance.Antibiotics (Basel, Switzerland) · 2024Review
- Hospital Antibiotic Consumption before and during the COVID-19 Pandemic in Hungary.Antibiotics (Basel, Switzerland) · 2024Article
- Antibiotic resistance and the COVID-19 pandemic: A dual crisis with complex challenges in LMICs.Health science reports · 2023Article
- Enhancing Biocidal Capability in Cuprite Coatings.ACS biomaterials science & engineering · 2023Article
- Antibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023Article
- Enhanced Antibacterial Activity of Substituted Derivatives of NCR169C Peptide.International journal of molecular sciences · 2023Article
- Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic.Frontiers in molecular biosciences · 2023Review
- Observational
- Impact of COVID-19 pandemic on antifungal consumption: a multicenter retrospective analysis.Critical care (London, England) · 2022Article
- Human microbiota drives hospital-associated antimicrobial resistance dissemination in the urban environment and mirrors patient case rates.Microbiome · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Ebrahim AfshinnekooDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, USA.
Chandrima BhattacharyaDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, USA.
Ana Burguete-GarcíaCenter for Research on Infectious Diseases, National Institute of Public Health, Cuernavaca, Mexico.
Eduardo Castro-NallarCenter for Bioinformatics and Integrative Biology, Universidad Andres Bello, Santiago, Chile.
Youping DengDepartment of Quantitative Health Sciences, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, USA.
Christelle DesnuesAix-Marseille University, University of Toulon, National Center for Scientific Research, French National Research Institute for Sustainable Development, Mediterranean Institute of Oceanography, Marseille, France.
Emmanuel Dias-NetoMedical Genomics Group, A C Camargo Cancer Center and LIM-27, Institute of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Eran ElhaikDepartment of Biology, Lund University, Lund, Sweden.
Gregorio IraolaMicrobial Genomics Laboratory, Institut Pasteur Montevideo, Montevideo, Uruguay.
Soojin JangDiscovery of Biology, Antibacterial Resistance Laboratory, Institut Pasteur Korea, Seongnam, South Korea.
Paweł P ŁabajMałopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Christopher E MasonDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, USA.
Niranjan NagarajanGenome Institute of Singapore, ASTAR and Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Michael PoulsenSection for Ecology and Evolution, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Bharath PrithivirajDepartment of Biology, Brooklyn College of the City University of New York, New York, USA.
Rania SiamUniversity of Medicine and Health Sciences, Basettere, St Kitts and Nevis.
Tieliu ShiThe Center for Bioinformatics and Computational Biology, Shanghai Key Laboratory of Regulatory Biology, the Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
Haruo SuzukiFaculty of Environment and Information Studies, Keio University, Kanagawa, Japan.
Johannes WernerHigh Performance and Cloud Computing Group, Zentrum für Datenverarbeitung, Eberhard Karls University of Tübingen, Tübingen, Germany.
Maria Mercedes ZambranoMolecular Genetics, Corporación Corpogen and Universidad Central, Bogotá, Colombia.
Malay BhattacharyyaCentre for Artificial Intelligence and Machine Learning, Machine Intelligence Unit, Indian Statistical Institute, Kolkata 700108, India.
MetaSUB Consortium
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19 Drug TreatmentAnti-Bacterial AgentsDrug Resistance, BacterialHumansSARS-CoV-2Anti-Bacterial Agents
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.